Viskase Holdings, Inc. earnings releases VISK

Annual Quarterly

Viskase Holdings, Inc. last reported quarterly results on Oct 31, 2012, for the quarter ended Sep 30, 2012. It usually reports 31–72 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 31–72 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released	Quarter	Revenue	Net income	Diluted EPS
Oct 31, 2012 31 days after quarter end	— ended Sep 30, 2012	—	—	—
Aug 1, 2012 32 days after quarter end	— ended Jun 30, 2012	—	—	—
May 2, 2012 32 days after quarter end	— ended Mar 31, 2012	—	—	—
Mar 12, 2012 72 days after quarter end	— ended Dec 31, 2011	—	—	—
Nov 3, 2011 34 days after quarter end	— ended Sep 30, 2011	—	—	—
Aug 4, 2011 35 days after quarter end	— ended Jun 30, 2011	—	—	—
May 6, 2011 36 days after quarter end	— ended Mar 31, 2011	—	—	—
Feb 17, 2011 48 days after quarter end	— ended Dec 31, 2010	—	—	—

Company profile

Industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as: VISK (OTC)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Lombard, IL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 727510
Former names: ENZON PHARMACEUTICALS, INC. (until Mar 25, 2026); ENZON PHARMACEUTICALS INC (until Feb 23, 2016); ENZON PHARMACEUTICALS INC (until Mar 22, 2006); ENZON PHARMACEUTICAL INC (until Dec 10, 2002); ENZON INC (until Dec 9, 2002)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.